The client is currently taking lisinopril 5 mg PO daily
🩺 Lisinopril is an ACE inhibitor that reduces aldosterone secretion and can increase the serum potassium level.
🩺 Spironolactone is a potassium-sparing diuretic that also blocks aldosterone and promotes potassium retention.
🩺 Administering these medications together significantly increases the client’s risk for severe hyperkalemia.
🩺 This interaction is especially dangerous because the client already has elevated potassium and impaired renal function.
🩺 The nurse should report the concurrent lisinopril therapy before administering the newly prescribed spironolactone.
Sodium 130 mEq/L
🩺 A sodium level of 130 mEq/L indicates hyponatremia, which can be worsened by diuretic therapy.
🩺 Spironolactone promotes sodium and water excretion while retaining potassium.
🩺 Further sodium loss can increase the risk for weakness, confusion, headache, seizures, and other neurological complications.
🩺 The sodium imbalance should be evaluated before spironolactone is initiated, particularly in a client with renal impairment.
🩺 The nurse should report this abnormal laboratory result so the provider can determine whether the medication is safe.
Potassium 5.6 mEq/L
🩺 A potassium level of 5.6 mEq/L indicates hyperkalemia, which is a major contraindication to spironolactone therapy.
🩺 Spironolactone blocks aldosterone and decreases renal potassium excretion, causing additional potassium retention.
🩺 Further elevation can produce muscle weakness, paresthesia, conduction abnormalities, life-threatening dysrhythmias, and cardiac arrest.
🩺 The risk is increased because the client is also taking lisinopril, which can elevate potassium.
🩺 The nurse should withhold the medication and immediately report the elevated potassium level to the provider.
BUN 30 mg/dL
🩺 A BUN level of 30 mg/dL is elevated and suggests decreased renal clearance, dehydration, or another form of renal dysfunction.
🩺 Spironolactone depends on adequate kidney function for safe elimination and electrolyte regulation.
🩺 Impaired renal function increases the risk that potassium will accumulate to dangerous levels.
🩺 The elevated BUN is especially concerning when considered with the client’s markedly elevated creatinine level.
🩺 The nurse should report this result before administering spironolactone so renal function can be further evaluated.
Creatinine 3 mg/dL
🩺 A creatinine level of 3 mg/dL indicates significant renal impairment.
🩺 Clients with severely reduced kidney function cannot excrete potassium effectively, increasing the risk for spironolactone-induced hyperkalemia.
🩺 Spironolactone is generally avoided or used with extreme caution in clients with substantial renal dysfunction.
🩺 The combination of renal impairment, existing hyperkalemia, and concurrent lisinopril therapy creates a high risk for a life-threatening electrolyte disturbance.
🩺 The nurse should report the elevated creatinine and clarify the prescription before administering the medication.